NEWS IN BRIEF: Price concessions; Scottish integration; Hollowood; Co-op; Blood pressure monitors

The latest essential pharmacy stories from the web and papers in our brand-new daily news round-up.

Further price concessions announced by PSNC

The Department of Health have granted ten price concessions for October 2015. No endorsements are required as these prices will automatically be applied to this month's prescriptions.

Scotland unveils new plans to support integration

Increasing the number of GPs in training will support the integration of pharmacists into ‘community health hubs’, Scotland’s First Minister Nicola Sturgeon has announced.

Related Article: Payment percentage for statutory branded medicines scheme drops to 16.5%

During the inaugural Health and Social Care Alliance lecture in Edinburgh, Sturgeon said GPs are at the heart of multidisciplinary teams that include pharmacists and other specialists as part of the transformation of primary care.

The number of training places for GPs will increase from 300 to 400 a year from next year with the help of £20m investment while £16m is earmarked to recruit 140 pharmacists into the integrated workforce.

Hollowood Chemists continues rapid growth

Hollowood Chemists have bought six WA Salter (Chemists) premises across Lancashire and Merseyside in a multi-million pound deal.

The acquisition increases the size of the independently owned group of pharmacies to 17 establishments.

In August 2014, the Cheadle-based pharmacy group added five pharmacies to its books after buying shares in J Simpson Chemists and Clamary.

Lincolshire Co-op multi-purpose site to include pharmacy in proposed £750,000 revamp

Related Article: Research review: a look at the latest clinical papers

A planning application to integrate a pharmacy and post office into the existing Lincolnshire Co-op premises has been submitted.

The £750,000 plans incorporate the nearby pharmacy in Holbeach as part of the project that will also see a food shop, library and post office housed under the same roof.

The Co-op already runs the existing pharmacy and an application will be made to NHS England for its relocation.

Blood pressure monitors approved by hypertension societies

Following testing, Alvita’s arm and advanced arm blood pressure monitors have been clinically validated to meet the British and European Hypertension Society standards.

Related Article: MenB vaccination programme to be rolled out in pharmacies

The European Hypertension Society standard has been given to Alvita wrist, arm and advanced arm blood pressure monitors.

The British Hypertension Society (BHS) standard has been given to the Alvita arm and advanced arm blood pressure monitors. The BHS does not endorse wrist monitors.

Ritu Bhardwaj, senior product manager for Alvita, said: “This gives pharmacists and their patient’s confidence in our products and the Alvita brand, to ensure this high-risk condition can be effectively and efficiently monitored at home.”

Want news like this straight to your inbox?
Register for full access to the site and our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.